ADDF- AFTD Accelerating Drug Discovery for Frontotemporal Degeneration

ADDF and AFTD seek to accelerate and support innovative drug discovery programs for FTD through this Request for Proposals. 

The RFP supports:

• Lead optimization of novel disease-modifying compounds.
• In vivo testing of novel lead compounds, biologics, or repurposed drug candidates

Funding: $150,000

Duration: 1 year

Research Authority due date: 15.5.22

LOI (required) due date: 20.5.22

Full proposal due date: 30.7.22